JAK3 and acute lymphoblastic leukemia: The test on human patients reveals mutations in KRAS, PTPN11, PAX5, NRAS, and JAK3 in divergent types of B-ALL involving PAX5-ELN B-ALL and leukemia due to PAX5-rearrangement.[73]